FGFR Inhibitor Chemo Linked With Ocular Toxicity

Patients with metastatic cancer undergoing chemotherapy with fibroblast growth factor receptor (FGFR) inhibitors may experience a novel ocular toxicity, a new case series from Spain suggests.
Reuters Health Information

Full Story →